Clinical Trial Update: Safety and Efficacy of Fluoxetine in Juvenile Fibromyalgia [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluated the safety and efficacy of fluoxetine in juvenile fibromyalgia. The study is completed and results were posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fibromyalgia
• Juvenile Fibromyalgia

Drugs mentioned

• Fluoxetine (Fluoxetine)

Snippet

Sponsor: University of Cincinnati | Conditions: Juvenile Primary Fibromyalgia Syndrome (JPFS), Fibromyalgia | Phase 3 | Status: COMPLETED | Results posted: 2013-02-15